Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis

Condition:   SARS-CoV Infection Intervention:   Drug: hydroxychloroquine Sponsors:   Regional Center for Disease Control and Prevention, Jordan;   Farhat Hached Hospital, Tunisia;   Fattouma Bourguiba, Tunisia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials